N-((5-(4-(3-chloro-4-(3-fluorobenzyloxy)phenylamino)pyrimidin-5-yl)isoxazol-3-yl)methyl)acrylamide | 1328624-30-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: N-((5-(4-(3-chloro-4-(3-fluorobenzyloxy)phenylamino)pyrimidin-5-yl)isoxazol-3-yl)methyl)acrylamide
• 英文别名: N-[[5-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]pyrimidin-5-yl]-1,2-oxazol-3-yl]methyl]prop-2-enamide
• CAS: 1328624-30-1
• 化学式: C₂₄H₁₉ClFN₅O₃
• 分子量: 479.898
• InChiKey: XPPYPNCAANLGMD-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.1
• 重原子数：
  34
• 可旋转键数：
  9
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.08
• 拓扑面积：
  102
• 氢给体数：
  2
• 氢受体数：
  8

文献信息

• [EN] NOVEL PYRIMIDINE DERIVATIVE FOR INHIBITING THE GROWTH OF CANCER CELLS<br/>[FR] NOUVEAU DÉRIVÉ DE LA PYRIMIDINE POUR L'INHIBITION DE LA CROISSANCE DES CELLULES CANCÉREUSES
  申请人：HANMI HOLDINGS CO LTD

  公开号：WO2011099764A2

  公开（公告）日：2011-08-18

  The present invention provides a novel pyrimidine derivative or pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising same, which can effectively inhibit the growth of cancer cells induced by the overexpression of EGFR including subtypes and also prevents the development of drug resistance caused by the mutation of EGFR tyrosine kinase including subtypes.